CI
TAK icon

Corient IA’s Takeda Pharmaceutical TAK Stock Holding History

Corient IA’s Portfolio TAK Stock Details TAK Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$276K Hold
14,880
– – 0.26% 157
2025
Q4 		$232K Sell
14,880
-10,120
-40% -$145K 0.22% 186
2025
Q3 		$366K Sell
25,000
-15,000
-38% -$223K 0.27% 145
2025
Q2 		$618K Hold
40,000
– – 0.36% 86
2025
Q1 		$595K Buy
+40,000
New +$560K 0.42% 71

Other funds holding TAK

Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Adage Capital Partners
Adage Capital Partners Boston, Massachusetts $64.8B AUM 42.7% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return
BIP
Brandes Investment Partners La Jolla, California $14.1B AUM 25.52% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Arrowstreet Capital
Arrowstreet Capital Boston, Massachusetts $185B AUM 39.58% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return

Corient IA's TAK Position: Q1 2026 in Review

Corient IA held its Takeda Pharmaceutical (TAK) position steady in Q1 2026 at 14,880 shares worth $276K. The position accounts for 0.26% of the portfolio, ranked #157.

Corient IA first reported a position in TAK in Q1 2025 and has held it in 5 quarters since. The position peaked at $618K in Q2 2025. 358 funds tracked by Wall St. Rank hold TAK as of Q1 2026.

  • Corient IA held 14,880 shares of Takeda Pharmaceutical worth $276K as of Q1 2026.
  • Corient IA left its Takeda Pharmaceutical share count unchanged in Q1 2026.
  • Takeda Pharmaceutical made up 0.26% of Corient IA's portfolio in Q1 2026, its #157 holding.
  • Corient IA first reported a position in Takeda Pharmaceutical in Q1 2025 and has held it in 5 quarters since.
  • Corient IA's Takeda Pharmaceutical position peaked at $618K in Q2 2025.
  • 358 funds tracked by Wall St. Rank held Takeda Pharmaceutical as of Q1 2026.

Based on Corient IA's 13F filing for Q1 2026, filed 14 May 2026.